secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rain Oncology Inc. (—)
CIK:        0001724979
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001193125-23-044873
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rain Oncology amends bylaws to update stockholder nomination rules and DGCL provisions
--------------------------------------------------------------------------------

- Board adopted amended and restated bylaws effective February 15, 2023.
- Enhanced disclosure requirements for stockholder director nominations and business proposals, aligning with Rule 14a-19.
- Updated provisions to reflect recent amendments to Delaware General Corporation Law.
- Requires stockholder soliciting proxies to use a proxy card color other than white, reserving white for Board.
- Includes ministerial, clarifying, and conforming changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724979/000119312523044873/0001193125-23-044873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724979/000119312523044873/d431240d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-044873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer